Medacta Group SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0468525222
CHF
153.80
18.8 (13.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

High Debt Company with a Debt to Equity ratio (avg) at times

  • Poor long term growth as Operating profit has grown by an annual rate 27.06% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2

Flat results in Jun 24

3

With ROE of 23.16%, it has a Very Expensive valuation with a 7.53 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CHF 3,424 Million ()

stock-summary
P/E

33.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.43

stock-summary
Return on Equity

23.16%

stock-summary
Price to Book

8.63

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
19.22%
0%
19.22%
6 Months
40.07%
0%
40.07%
1 Year
21.1%
0%
21.1%
2 Years
35.39%
0%
35.39%
3 Years
44.82%
0%
44.82%
4 Years
26.9%
0%
26.9%
5 Years
90.82%
0%
90.82%

Medacta Group SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
13.90%
EBIT Growth (5y)
27.06%
EBIT to Interest (avg)
6.05
Debt to EBITDA (avg)
1.01
Net Debt to Equity (avg)
0.46
Sales to Capital Employed (avg)
1.04
Tax Ratio
16.94%
Dividend Payout Ratio
19.79%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.61%
ROE (avg)
20.96%

Valuation key factors

Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
7.53
EV to EBIT
30.25
EV to EBITDA
18.57
EV to Capital Employed
5.57
EV to Sales
5.19
PEG Ratio
0.52
Dividend Yield
NA
ROCE (Latest)
18.40%
ROE (Latest)
23.16%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Medacta Group SA"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 13.08% vs 11.82% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -0.86% vs -16.70% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "496.20",
          "val2": "438.80",
          "chgp": "13.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "130.60",
          "val2": "120.50",
          "chgp": "8.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.60",
          "val2": "3.70",
          "chgp": "78.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.80",
          "val2": "-5.50",
          "chgp": "67.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "46.00",
          "val2": "46.40",
          "chgp": "-0.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "150.40%",
          "val2": "158.10%",
          "chgp": "-0.77%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'23stock-summary

Dec'23
Dec'22
Change(%)
Net Sales
496.20
438.80
13.08%
Operating Profit (PBDIT) excl Other Income
130.60
120.50
8.38%
Interest
6.60
3.70
78.38%
Exceptional Items
-1.80
-5.50
67.27%
Consolidate Net Profit
46.00
46.40
-0.86%
Operating Profit Margin (Excl OI)
150.40%
158.10%
-0.77%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 13.08% vs 11.82% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -0.86% vs -16.70% in Dec 2022

stock-summaryCompany CV
About Medacta Group SA stock-summary
stock-summary
Medacta Group SA
Pharmaceuticals & Biotechnology
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
Company Coordinates stock-summary
Company Details
Strada Regina 34 , CASTEL SAN PIETRO None : 6874
stock-summary
Tel: 41 91 6966060
stock-summary
stock-summary
Registrar Details